Comments on: Fertility-sparing treatment for intramucous, moderately differentiated, endometrioid endometrial cancer: a Gynecologic Cancer Inter-Group (GCIG) study
- PMID: 33078601
- PMCID: PMC7593221
- DOI: 10.3802/jgo.2020.31.e96
Comments on: Fertility-sparing treatment for intramucous, moderately differentiated, endometrioid endometrial cancer: a Gynecologic Cancer Inter-Group (GCIG) study
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Comment on
-
Fertility-sparing treatment for intramucous, moderately differentiated, endometrioid endometrial cancer: a Gynecologic Cancer Inter-Group (GCIG) study.J Gynecol Oncol. 2020 Sep;31(5):e74. doi: 10.3802/jgo.2020.31.e74. J Gynecol Oncol. 2020. PMID: 32808500 Free PMC article.
References
-
- Park JY, Kim DY, Kim TJ, Kim JW, Kim JH, Kim YM, et al. Hormonal therapy for women with stage IA endometrial cancer of all grades. Obstet Gynecol. 2013;122:7–14. - PubMed
-
- Park JY, Lee JJ, Choi HJ, Song IH, Sung CO, Kim HO, et al. The value of preoperative positron emission tomography/computed tomography in node-negative endometrial cancer on magnetic resonance imaging. Ann Surg Oncol. 2017;24:2303–2310. - PubMed
-
- Lee GW, Park JY, Kim DY, Suh DS, Kim JH, Kim YM, et al. Usefulness of sentinel lymph node mapping using indocyanine green and fluorescent imaging in the diagnosis of lymph node metastasis in endometrial cancer. J Obstet Gynaecol. 2020 Forthcoming. - PubMed
-
- Yuk JS, Song JY, Lee JH, Park WI, Ahn HS, Kim HJ. Levonorgestrel-releasing intrauterine systems versus oral cyclic medroxyprogesterone acetate in endometrial hyperplasia therapy: a meta-analysis. Ann Surg Oncol. 2017;24:1322–1329. - PubMed